Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
A Smarter Way to Lose Weight GLP 1 weight loss represents a powerful shift from reactive dieting to science-backed, medically guided transformation
[5] Orer GE, Guzel NA
Understanding the symptoms is crucial for anyone taking Ozempic, as recognising these episodes early allows for appropriate management and medical review
14 A calculator to assess cardiovascular disease risk in people with type 2 diabetes is available here: Clinical scenarios where empagliflozin or dulaglutide are recommended, but not funded The recently released type 2 diabetes management guidelines developed by the New Zealand Society for the Study of Diabetes (NZSSD), and supported by the Ministry of Health, state that while the Special Authority criteria for empagliflozin and GLP-1 receptor agonists ensure access for those at high risk of cardiovascular and renal disease, the funding restriction is not fully consistent with best practice
Members can call the number on their member ID card for more information about eligibility
